Novocure (NVCR) Issues Positive Update on TTFields Study in Certain Glioblastoma Patients

Go back to Novocure (NVCR) Issues Positive Update on TTFields Study in Certain Glioblastoma Patients
(NASDAQ: NVCR) Delayed: 177.98 -1.29 (0.72%)
Previous Close $179.27    52 Week High $28.95 
Open $177.47    52 Week Low $5.95 
Day High $178.32    P/E N/A 
Day Low $175.01    EPS $0.00 
Volume 26,496